Cancer Research New Funding Opportunities

*Limited Submission Opportunity

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

*For full program details, see Endeavor | The Mark Foundation for Cancer Research.

Key Details:

• Funding: $3,000,000 total over 3 years, with funds distributed based on effort and a 10% indirect cost cap.
• Institutional Limit: The DLDCCC may submit up to two proposals — the first may address any cancer type; the second must focus on upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.
• Eligibility: PIs and co-PIs must hold independent faculty appointments (tenure-track or equivalent). There are no restrictions on citizenship or geography.
• Team Structure: One PI and 2–8 co-PIs; teams must include at least three investigators.
  Internal Submission Instructions:

If you are interested, please upload your current NIH biosketch, Other Support document, and a 3-page LOI as a single PDF file via BCM Award Hub by Thursday, July 10, 2025. 

1. Team Structure Document (1 page) - List each team member and their role in alignment with RFA team roles
2. General Audience/Lay Summary (2-3 Sentences)
3. Research summary (1-2pages)
4. NIH Biosketch - All proposed team members
5. NIH Other Support Document (Current and Pending) - PI and Co-PI only

Submissions will be reviewed by a DLDCCC-appointed panel, and selected nominee(s) will move forward for LOI submission to The Mark Foundation by Sept. 3, 2025.

Please name your LOI file as follows:

NAME OF SPONSOR_PI LAST NAME_LOI

Example: CPRIT_SMITH_LOI

Please review the award opportunity carefully to ensure alignment with your research. 
For questions, please contact the DLDCCC grants team at DLDCCCgrants@bcm.edu.

Research Grants

Application Deadline: July 15, 2025

Budget: $100,000 over 2 years

Award: Research grants fund promising scientists for innovative projects with the potential to make substantial contributions to cancer prevention and early detection. Projects that evaluate the potential for dissemination and implementation into clinical and community health settings are highly encouraged.

Please contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Fellowship Award

Deadline: August 15, 2025

Amount: $294,000 over four years.

Supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country.

Research Grant: Seed Grant

Deadline: Aug. 15, 2025

Amount: $75,000 over 1 year

Award: Funds research in the following areas: treatment/therapy, patient care, early diagnosis, detection, cancer biology, basic science, prevention/metabolism and research core facilities.\

Please contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Community Grants

Application Deadline: Ongoing until funds are used.

Budget: $20,000-$40,000, for one year.

Award: The Colon Cancer Coalition seeks to provide funds, to liked-minded partners advancing colon cancer research. Funds must be used on programs that will benefit individuals in and around the event city where the money is raised. Priority will be given to programs working to increase screening for adults over 50 to reach the national goal of 80%, patient screening navigation, or addressing young adult onset colorectal cancer.

Contact: Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations at lyndsie.whitehead@bcm.edu for additional information.

Open Proposals Program
Application Deadline: Funding is available on a rolling basis and new grants are awarded frequently.
Budget: $50,000 ~ $828,027, from 6 months to 36 months (average $224,000 for 2 years). NTAP supports indirect costs at a maximum of 10% of direct costs.  

Award: The Johns Hopkins University School of Medicine - Neurofibromatosis Therapeutic Acceleration Program (NTAP) supports research projects designed to accelerate development of effective treatments for NF1 associated peripheral nerve sheath tumors.  NTAP’s Open Proposal program is open to any stage of drug development.  However, proposal must focus on the peripheral nerve tumors of NF1 (Cutaneous, Plexiform and Atypical).

Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations for additional information.